Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 2013; Volume 84,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Amoresano, Angela

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971

B

  1. Banghart, Matthew R.

    1. You have access
      Caged Naloxone Reveals Opioid Signaling Deactivation Kinetics
      Matthew R. Banghart, John T. Williams, Ruchir C. Shah, Luke D. Lavis and Bernardo L. Sabatini
      Molecular Pharmacology November 2013, 84 (5) 687-695; DOI: https://doi.org/10.1124/mol.113.088096
  2. Benkhalifa, Rym

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  3. Borghese, Cecilia M.

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  4. Broemstrup, Torben

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  5. Butcher, Adrian J.

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783

C

  1. Carlsson, Jens

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  2. Chamulitrat, Walee

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039
  3. Choi, Jung Yoon

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502
  4. Christiansen, Elisabeth

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  5. Cullins, Madeline A.

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692

D

  1. Davis, Thomas P.

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298

E

  1. El Ayeb, Mohamed

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971

F

  1. Fujiwara, Ryoichi

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112

G

  1. Gan-Schreier, Hongying

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039

H

  1. Harris, R. Adron

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  2. Hartzell, H. Criss

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502
  3. Heathcote, Helen

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  4. Heusser, Stephanie A.

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  5. Howard, Rebecca J.

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  6. Hudson, Brian D.

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  7. Hwang, Seok Jin

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502

I

  1. Itoh, Tomoo

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112

J

  1. Jansson, Patric J.

    1. You have access
      Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
      Alexandra E. Stacy, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology November 2013, 84 (5) 655-669; DOI: https://doi.org/10.1124/mol.113.088609
  2. Jung, Jonghoon

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502

K

  1. Kawana, Makiko

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112
  2. Kim, Felix J.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  3. Kim, Jeongyeon

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502
  4. Konrad, Maik

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  5. Kouno, Emi

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112
  6. Krügel, Ute

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843

L

  1. Landoulsi, Zied

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  2. Laracuente, Mei-Li

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298
  3. Lavis, Luke D.

    1. You have access
      Caged Naloxone Reveals Opioid Signaling Deactivation Kinetics
      Matthew R. Banghart, John T. Williams, Ruchir C. Shah, Luke D. Lavis and Bernardo L. Sabatini
      Molecular Pharmacology November 2013, 84 (5) 687-695; DOI: https://doi.org/10.1124/mol.113.088096
  4. Lee, C. Justin

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502
  5. Lee, Ui S.

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  6. Liebisch, Gerhard

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039
  7. Lindahl, Erik

    1. You have access
      Functional Validation of Virtual Screening for Novel Agents with General Anesthetic Action at Ligand-Gated Ion Channels
      Stephanie A. Heusser, Rebecca J. Howard, Cecilia M. Borghese, Madeline A. Cullins, Torben Broemstrup, Ui S. Lee, Erik Lindahl, Jens Carlsson and R. Adron Harris
      Molecular Pharmacology November 2013, 84 (5) 670-678; DOI: https://doi.org/10.1124/mol.113.087692
  8. Longen, Charles G.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809

M

  1. Mackenzie, Amanda E.

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  2. Marino, Gennaro

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  3. Marino, Jacqueline C.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  4. Miceli, Francesco

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  5. Milligan, Graeme

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  6. Mohr, Florian

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843

N

  1. Narawa, Tomoya

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112

O

  1. Oberwinkler, Johannes

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  2. Oh, Soo-Jin

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502

P

  1. Palmese, Angelo

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  2. Pasternak, Gavril W.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  3. Pathil, Anita

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039
  4. Pediani, John D.

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783

R

  1. Richardson, Des R.

    1. You have access
      Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
      Alexandra E. Stacy, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology November 2013, 84 (5) 655-669; DOI: https://doi.org/10.1124/mol.113.088609
  2. Rizun, Oleksandr

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  3. Roh, Eun Joo

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502
  4. Ronaldson, Patrick T.

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298

S

  1. Sabatini, Bernardo L.

    1. You have access
      Caged Naloxone Reveals Opioid Signaling Deactivation Kinetics
      Matthew R. Banghart, John T. Williams, Ruchir C. Shah, Luke D. Lavis and Bernardo L. Sabatini
      Molecular Pharmacology November 2013, 84 (5) 687-695; DOI: https://doi.org/10.1124/mol.113.088096
  2. Sanchez-Covarrubias, Lucy

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298
  3. Schaefer, Michael

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  4. Schmitz, Gerd

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039
  5. Schrock, Joel M.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  6. Shah, Ruchir C.

    1. You have access
      Caged Naloxone Reveals Opioid Signaling Deactivation Kinetics
      Matthew R. Banghart, John T. Williams, Ruchir C. Shah, Luke D. Lavis and Bernardo L. Sabatini
      Molecular Pharmacology November 2013, 84 (5) 687-695; DOI: https://doi.org/10.1124/mol.113.088096
  7. Shimpukade, Bharat

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  8. Slosky, Lauren M.

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298
  9. Spino, Christina M.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  10. Stabler, Stacy M.

    1. You have access
      Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress
      Joel M. Schrock, Christina M. Spino, Charles G. Longen, Stacy M. Stabler, Jacqueline C. Marino, Gavril W. Pasternak and Felix J. Kim
      Molecular Pharmacology November 2013, 84 (5) 751-762; DOI: https://doi.org/10.1124/mol.113.087809
  11. Stacy, Alexandra E.

    1. You have access
      Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
      Alexandra E. Stacy, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology November 2013, 84 (5) 655-669; DOI: https://doi.org/10.1124/mol.113.088609
  12. Straub, Isabelle

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  13. Stremmel, Wolfgang

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039
  14. Sumida, Kyohei

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112

T

  1. Taglialatela, Maurizio

    1. You have access
      Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom
      Zied Landoulsi, Francesco Miceli, Angelo Palmese, Angela Amoresano, Gennaro Marino, Mohamed El Ayeb, Maurizio Taglialatela and Rym Benkhalifa
      Molecular Pharmacology November 2013, 84 (5) 763-773; DOI: https://doi.org/10.1124/mol.113.088971
  2. Takano, Shuhei

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112
  3. Teichert, Jens

    1. You have access
      Flavanones That Selectively Inhibit TRPM3 Attenuate Thermal Nociception In Vivo
      Isabelle Straub, Ute Krügel, Florian Mohr, Jens Teichert, Oleksandr Rizun, Maik Konrad, Johannes Oberwinkler and Michael Schaefer
      Molecular Pharmacology November 2013, 84 (5) 736-750; DOI: https://doi.org/10.1124/mol.113.086843
  4. Thompson, Brandon J.

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298
  5. Tobin, Andrew B.

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783
  6. Tukey, Robert H.

    1. You have access
      Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemia
      Kyohei Sumida, Makiko Kawana, Emi Kouno, Tomoo Itoh, Shuhei Takano, Tomoya Narawa, Robert H. Tukey and Ryoichi Fujiwara
      Molecular Pharmacology November 2013, 84 (5) 679-686; DOI: https://doi.org/10.1124/mol.113.088112

U

  1. Ulven, Trond

    1. You have access
      The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
      Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie, Adrian J. Butcher, John D. Pediani, Elisabeth Christiansen, Helen Heathcote, Andrew B. Tobin, Trond Ulven and Graeme Milligan
      Molecular Pharmacology November 2013, 84 (5) 710-725; DOI: https://doi.org/10.1124/mol.113.087783

V

  1. Vanderah, Todd W.

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298

W

  1. Williams, John T.

    1. You have access
      Caged Naloxone Reveals Opioid Signaling Deactivation Kinetics
      Matthew R. Banghart, John T. Williams, Ruchir C. Shah, Luke D. Lavis and Bernardo L. Sabatini
      Molecular Pharmacology November 2013, 84 (5) 687-695; DOI: https://doi.org/10.1124/mol.113.088096

X

  1. Xu, Weihong

    1. You have access
      Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes
      Walee Chamulitrat, Gerhard Liebisch, Weihong Xu, Hongying Gan-Schreier, Anita Pathil, Gerd Schmitz and Wolfgang Stremmel
      Molecular Pharmacology November 2013, 84 (5) 696-709; DOI: https://doi.org/10.1124/mol.113.088039

Y

  1. Yu, Kuai

    1. You have access
      MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
      Soo-Jin Oh, Seok Jin Hwang, Jonghoon Jung, Kuai Yu, Jeongyeon Kim, Jung Yoon Choi, H. Criss Hartzell, Eun Joo Roh and C. Justin Lee
      Molecular Pharmacology November 2013, 84 (5) 726-735; DOI: https://doi.org/10.1124/mol.113.087502

Z

  1. Zhang, Yifeng

    1. You have access
      Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor–Dependent Mechanism
      Lauren M. Slosky, Brandon J. Thompson, Lucy Sanchez-Covarrubias, Yifeng Zhang, Mei-Li Laracuente, Todd W. Vanderah, Patrick T. Ronaldson and Thomas P. Davis
      Molecular Pharmacology November 2013, 84 (5) 774-786; DOI: https://doi.org/10.1124/mol.113.086298
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 84 (5)
Molecular Pharmacology
Vol. 84, Issue 5
1 Nov 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics